104 related articles for article (PubMed ID: 17786354)
1. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.
Rangaswami H; Kundu GC
Oncol Rep; 2007 Oct; 18(4):909-15. PubMed ID: 17786354
[TBL] [Abstract][Full Text] [Related]
2. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
[TBL] [Abstract][Full Text] [Related]
5. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
[TBL] [Abstract][Full Text] [Related]
7. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
8. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.
Wu CY; Hsieh HL; Sun CC; Yang CM
Glia; 2009 Dec; 57(16):1775-89. PubMed ID: 19455716
[TBL] [Abstract][Full Text] [Related]
9. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
[TBL] [Abstract][Full Text] [Related]
10. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
[TBL] [Abstract][Full Text] [Related]
11. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
12. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation.
Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M
Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.
Philip S; Kundu GC
J Biol Chem; 2003 Apr; 278(16):14487-97. PubMed ID: 12473670
[TBL] [Abstract][Full Text] [Related]
14. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
[TBL] [Abstract][Full Text] [Related]
15. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
16. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
Xiao L; Lang W
Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
[TBL] [Abstract][Full Text] [Related]
17. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
Frey AB; Wali A; Pass H; Lonardo F
Histopathology; 2007 May; 50(6):720-6. PubMed ID: 17493236
[TBL] [Abstract][Full Text] [Related]
20. MEKK1 induces c-Jun complexes that act as negative regulators for cell survival and proliferation of HCC cells.
Komoda F; Shino Y; Hirano T; Okutomi Y; Okamoto H; Hayashi Y; Suyama T; Ebara M; Saisho H; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):553-9. PubMed ID: 12168099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
